<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03108391</url>
  </required_header>
  <id_info>
    <org_study_id>PSH-2016-8</org_study_id>
    <nct_id>NCT03108391</nct_id>
  </id_info>
  <brief_title>A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients</brief_title>
  <official_title>A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to compare the performance of the Ambu AuraGain Laryngeal Mask Airway
      and LMA Supreme in normal airway patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ambu AuraGain Laryngeal Mask Airway is a newly designed supraglottic device. We design this
      study to test its clinical performance in normal airway patients, in comparison with LMA
      Supreme.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parellel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal leak pressure</measure>
    <time_frame>Up to 1 minute after the time of confirmed device placement</time_frame>
    <description>The airway pressure at which an airway leak is observed after successful placement of the device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insertion time</measure>
    <time_frame>Up to 1 minute on each insertion attempt</time_frame>
    <description>Time needed to insert the device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of insertion</measure>
    <time_frame>Up to 1 minute on each insertion attempt</time_frame>
    <description>Number of attempts to place the device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fiberoptic Grade of Laryngeal View</measure>
    <time_frame>Up to 1 minute after placement of device</time_frame>
    <description>Fiberoptic Grade of Laryngeal View through each device will be graded using a previously grading system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>2 hours after removal of the device</time_frame>
    <description>Patient will be evaluated for sore throat, dysphonia, stridor, dysphagia, blood stain on device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Supraglottic Airway</condition>
  <arm_group>
    <arm_group_label>Ambu AuraGain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive the Ambu AuraGain size 3 to size 5 based on manufacturer guidelines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LMA Supreme</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive the LMA Supreme size 3 to size 5 based on manufacturer guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ambu AuraGain</intervention_name>
    <arm_group_label>Ambu AuraGain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA Supreme</intervention_name>
    <arm_group_label>LMA Supreme</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists Ⅰ-Ⅲ classification

          -  Patients evaluated as eligible for a LMA

          -  Body Mass Index ≤35kg/m2

        Exclusion Criteria:

          -  Patients with known or predicted difficult airway

          -  Active respiratory infection

          -  Risk of aspiration

          -  Head and neck surgery

          -  Emergent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liu Juhui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Plastic Surgery Hospital, ChineseAMS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liu Juhui, MD</last_name>
    <phone>+8615210258001</phone>
    <email>liujuhui2006@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ChineseAMS</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100144</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Juhui, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Juhui Liu</investigator_full_name>
    <investigator_title>Plastic Surgery Hospital</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

